Bayer Operating Income 2012-2026 | BAYRY

Bayer operating income for the twelve months ending March 31, 2026 was $0.462B, a 146.91% decline year-over-year.

  • Bayer annual operating income for 2025 was $-1.219B, a 1485.95% increase from 2024.
  • Bayer annual operating income for 2024 was $-0.077B, a 111.6% decline from 2023.
  • Bayer annual operating income for 2023 was $0.662B, a 91.03% decline from 2022.

Bayer Operating Income 2012-2026 | BAYRY

  • Bayer annual operating income for 2025 was $-1.219B, a 1485.95% increase from 2024.
  • Bayer annual operating income for 2024 was $-0.077B, a 111.6% decline from 2023.
  • Bayer annual operating income for 2023 was $0.662B, a 91.03% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$1T
Johnson & Johnson (JNJ)$556.8B
AbbVie (ABBV)$406.4B
Roche Holding AG (RHHBY)$312.9B
Merck (MRK)$285.2B
Novartis AG (NVS)$284.2B
Novo Nordisk (NVO)$204.9B
Pfizer (PFE)$142.9B
Sanofi (SNY)$101.3B
Innoviva (INVA)$1.7B